Search Results

Filter Results

Reset filters

Date

All Dates

Past 7 Days 10

Past 30 Days 33

Past year 519

Custom range

Custom Date Range

Start date: End date:

Topic

All Topics

Public Health 1,697

States 1,279

Health Industry 1,248

Insurance 983

Health Care Costs 878

The Health Law 831

Elections 730

Cost and Quality 661

Pharmaceuticals 652

Medicaid 558

Courts 368

COVID-19 351

Medicare 343

Multimedia 319

California 288

Noticias En Español 271

Uninsured 264

Mental Health 254

Rural Health 192

Global Health Watch 190

Aging 115

Race and Health 113

Medi-Cal 35

HealthBent 20

Postcards 15

KFF Health News On Air 13

Covered California 9

Asking Never Hurts 4

Navigating Aging 2

KFF Health News Impact 2

The New Old Age 1

Content Type

All Content Types

Morning Briefing 1,519

Podcast 119

Story 1,733

Showing 1901-1920 of 3,373 results for "Donald Trump"

Sort by Relevance Date

Trump Sets Hyper-Ambitious Goal Of Having Vaccine By End Of Year Despite Experts’ Caution

May 18, 2020 Morning Briefing

President Donald Trump acknowledged that “Operation Warp Speed” is risky and expensive, but he still made grand promises to have the capacity to distribute 300 million doses in January. That year-end goal is a “very bold plan … a stretch goal if there ever was one,” warned NIH Director Francis Collins. While some experts say the unprecedented global race for a vaccine might shorten the expected timeline, there’s been a broad consensus that there aren’t too many corners left to cut without it being unsafe.

X
Facebook
LinkedIn
Email
Print

Costos adicionales bloquean el tratamiento para prevenir el VIH

By Michelle Andrews July 15, 2019 KFF Health News Original

Aunque muchas aseguradoras cubren PrEP, los costos por las pruebas adicionales que hay que realizarse pueden bloquear el acceso a esta terapia preventiva.

X
Facebook
LinkedIn
Email
Print

En Tijuana, madres migrantes esperan dos fechas límite: el parto y la corte

By Heidi de Marco July 26, 2019 KFF Health News Original

Más mujeres embarazadas deben vivir meses en refugios en la frontera, esperando por sus audiencias de asilo en EE.UU. Reciben poco o ninguna atención prenatal.

X
Facebook
LinkedIn
Email
Print

Not Every Industry Can Get Special Help From The Government. So Who Gets Bailed Out And Who Gets By On Generic Economic Aid?

March 16, 2020 Morning Briefing

President Donald Trump has already vowed to help both the cruise line industry and the airline industry. But what other industries are likely to get specialized attention as steps to flatten the curve of the outbreak have a devastating effect on everything from movie theaters to small businesses.

X
Facebook
LinkedIn
Email
Print

Summer Setbacks: The Long Road To Lower Drug Prices Hits Some Potholes

By Emmarie Huetteman July 24, 2019 KFF Health News Original

Efforts to control drug prices seemed on a glide path earlier this year after gaining traction at the White House and in Congress. But prospects today look less certain and highly controversial.

X
Facebook
LinkedIn
Email
Print

Trump Continued To Criticize Mail-In-Voting, But Many States See It As Inevitable

May 22, 2020 Morning Briefing

Surrounding his trip to Michigan, and election battleground, President Donald Trump was vocal about his opposition to mail-in-voting. But many states, even Republican-leaning ones, are mobilizing to make voting easier as experts predict a second virus wave in the fall. “Every once in a while you get the president of the United States popping up and screaming against vote-by-mail, but states and both political parties are organizing their people for it,” said Michael Waldman, the president of the Brennan Center for Justice at New York University. “It’s a bizarre cognitive dissonance.”

X
Facebook
LinkedIn
Email
Print

Study Finds Malaria Drug Doesn’t Prevent COVID-19 In Latest Knock Against Controversial Treatment

June 4, 2020 Morning Briefing

“As we say in Tennessee, ‘that dog won’t hunt’ — it didn’t work,” said William Schaffner, a professor of preventive medicine and infectious diseases at Vanderbilt University Medical Center. Debate over the drug hydroxychloroquine became politicized as President Donald Trump touted it as a “game changer.” But so far, studies have failed to find any benefit from the treatment. In other news, WHO has restarted its trials on the drug after pausing over safety concerns.

X
Facebook
LinkedIn
Email
Print

White House Questioning If Deaths Are Being Overcounted Despite Broad Consensus That Opposite Is True

May 14, 2020 Morning Briefing

Experts have been saying since the beginning of the crisis that deaths are being undercounted because of a lack of testing, and analyses of year-over-year deaths also indicate that thousands aren’t being included in the official COVID-19 fatality totals. But President Donald Trump and his advisers are starting to sow doubts about the numbers. Meanwhile, the official U.S. death toll stands at more than 84,000.

X
Facebook
LinkedIn
Email
Print

Trump, Cuomo Meet In Person To Talk Testing After Weeks Of Quarreling With And Praising Each Other

April 22, 2020 Morning Briefing

Both President Donald Trump and New York Gov. Andrew Cuomo (D) — who have displayed their tumultuous relationship through the pandemic — had good things to say about the conversation. Cuomo said that one of their main focuses was increasing federal support for testing in the states. Meanwhile, Cuomo says that New York will reopen on a rolling schedule, with some parts of the state lifting restrictions earlier than other hard-hit areas.

X
Facebook
LinkedIn
Email
Print

CDC Used To Be One Of World’s Preeminent Disease-Fighting Bodies, But Agency Gutted Under Trump

April 16, 2020 Morning Briefing

The CDC played a major role in eradicating smallpox, as well as the near-elimination of polio. Globally, it won acclaim for helping fight AIDS, Ebola and Zika. Now, under President Donald Trump, experts say its a non-entity in the battle against the coronavirus. In other news from the Trump administration: Vice President Mike Pence put to the test; HHS Secretary Alex Azar snubbed by White House; health experts getting pushed to side in briefings; and more.

X
Facebook
LinkedIn
Email
Print

Trump Warns That ‘Hard Days Lie Ahead’ As Task Force Projects Grim Death Totals Even With Shutdown Efforts

April 1, 2020 Morning Briefing

President Donald Trump and his coronavirus task force, including Drs. Anthony Fauci and Deborah Birx, struck a serious tone Tuesday saying Americans must brace for a “bad two weeks.” They also projected that at least 100,000 Americans could succumb to the coronavirus even with strict social distancing measures in place. Without the shutdown, the number would skyrocket higher.

X
Facebook
LinkedIn
Email
Print

Metrics-Focused Trump Laments Fact That Testing More People Means A Higher Case Count For U.S.

May 15, 2020 Morning Briefing

“We have more cases than anybody in the world,” President Donald Trump said. “But why? Because we do more testing. When you test, you have a case. When you test, you find something is wrong with people. If we didn’t do any testing, we would have very few cases.” Meanwhile, whereas scientists had been prominent players in the early days of the administration’s response efforts, they’re now being sidelined more and more.

X
Facebook
LinkedIn
Email
Print

For President Whose Re-Election Chances Are Tied To Economy, Outbreak Presents Trump Existential Political Threat

February 25, 2020 Morning Briefing

Global stocks plunged on Monday as investors finally began to adopt a more pessimistic view of the coronavirus outbreak’s impact on the world’s economy. For President Donald Trump, who has banked on strong growth to propel him into another four years in office, that could spell trouble ahead.

X
Facebook
LinkedIn
Email
Print

‘Everyone Who Wants A Test Can Get One’: How A Single Promise Could Weigh Heavily On Trump’s Reelection

April 21, 2020 Morning Briefing

In terms of political vulnerabilities, sometimes a simple statement can balloon into a defining issue of a campaign. For President Donald Trump, the administration’s missteps on testing in the early days of the outbreak may do just that. Meanwhile, as some governors and the president continue to trade accusations over testing, Maryland Gov. Larry Hogan (R) announced that he has obtained 500,000 kits from South Korea, crediting his wife Yumi Hogan in helping lock down the deal.

X
Facebook
LinkedIn
Email
Print

9% Of Adults Say They Would Delay Seeking COVID-19 Care Because Of Worries About Costs

April 28, 2020 Morning Briefing

Although Congress and President Donald Trump made testing free to patients, and some insurers are waiving copays and deductibles for treatment within their networks, the survey suggests such messages may not be getting to the public. In other costs news: halt in elective care offsets insurers’ COVID-19 costs; a portal is created for provider payments from HHS; and CMS suddenly suspends advance Medicare payments.

X
Facebook
LinkedIn
Email
Print

How A Straight-Shooting New Yorker Won Over The Public’s Attention

March 30, 2020 Morning Briefing

The Los Angeles Times takes a look at how Dr. Anthony Fauci got where he is serving under but Democratic and Republican presidents. Some have praised his ability to contradict President Donald Trump’s more optimistic messaging. Meanwhile, Fauci’s prediction that the death toll could climb past 100,000 may have swayed Trump’s decision to extend social distancing guidelines through April.

X
Facebook
LinkedIn
Email
Print

Trump Wants To ‘Open Up’ The Country By Easter Despite Public Health Experts’ Warnings

March 25, 2020 Morning Briefing

Public health experts caution that lifting social distancing recommendations would overwhelm the country’s health system and have fatal consequences. But President Donald Trump, who has tied his presidency to the success of the economy, seems to be getting restless. The suggestion that the country restart in two weeks kicked off a debate about the value of human life between the political parties.

X
Facebook
LinkedIn
Email
Print

The One-Two Punch That Changed Trump’s Mind On Re-Opening: Poll Numbers And Projected Deaths

March 31, 2020 Morning Briefing

President Donald Trump walked back optimistic projections that the country would start returning to normal by Easter. Reporting on what changed his mind shows that it wasn’t just the coronavirus forecasts that swayed him–voters’ opinions did as well. Meanwhile, a statistical model that the White House is consulting shows a death total that could climb past 84,000 Americans, though numbers shift daily with more information.

X
Facebook
LinkedIn
Email
Print

What’s To Become Of The 2020 Elections?

March 30, 2020 Morning Briefing

The coronavirus outbreak has upended the election season, and it’s hard to know how the following months will play out when it comes to politics and voting. Meanwhile, the outbreak has both deepened the partisan divide and created a shared experience for Americans to unify over. Meanwhile, 2020 Democratic front-runner Joe Biden criticizes President Donald Trump’s response to the crisis.

X
Facebook
LinkedIn
Email
Print

With Fate Of Coronavirus Vaccine Hanging In Balance, Trump Adopts Friendly Tone Toward Pharma

March 3, 2020 Morning Briefing

President Donald Trump met with pharma executives in a meeting that had once been billed as a scolding over high prices. But now that the industry is needed to help develop a vaccine for the emerging pandemic, Trump has taken a more congenial tone with the executives. Meanwhile, Stat takes a closer look at where everyone stands on developing coronavirus-related drugs and vaccines.

X
Facebook
LinkedIn
Email
Print

More From KFF Health News

An American flag blows in the wind next to a barbed-wire fence in front of a landscape of grasslands

End of Enhanced Obamacare Subsidies Puts Tribal Health Lifeline at Risk

New Medicaid Work Rules Likely To Hit Middle-Aged Adults Hard

A box of ivermectin tablets is shown in a pharmacy.

US Cancer Institute Studying Ivermectin’s ‘Ability To Kill Cancer Cells’

A photo of a woman sitting in a chair from the shoulders down. She is taking her blood pressure.

Obamacare Sign-Ups Drop, but the Extent Won’t Be Clear for Months